Advertisement

Javid J. Moslehi, MD, on Cardiovascular and Thrombotic Considerations of Kinase Inhibitors: The Case of BTK Inhibitors

First International Summit on Interventional Pharmacoeconomics

Advertisement

Related Videos

Deborah Collyar: What's In It for Patients?

Leonard B. Saltz, MD, on the Future of Interventional Pharmacoeconomics

Focus on Optimized Dosing of Ibrutinib Panel Discussion

Varsha Gandhi, PhD, on Ibrutinib

Gary L. Rosner, ScD, on Bayesian Non-Inferiority

Advertisement

Advertisement

Feb

13

Today In Oncology

ASCO and Conexiant Launch ASCO AI in Oncology

Demographic and Clinicopathologic Factors in Colorectal Adenoma Recurrence Risk

ASH Publishes Clinical Guidelines on AL Amyloidosis Diagnosis

FDA Approves TTFields Device for Pancreatic Cancer

Interval Cancer Rate With AI-Supported Mammography Screening

Advertisement

© 2026 HSP News Service, L.L.C.